Delivery Order SPE2DB20D7059-SPE2DB25FPYB4

Award Date 1/15/25
Potential Completion Date 1/16/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of oseltamivir phosphate 75 mg capsules. The $1,116.37 firm fixed-price contract has an ultimate completion date of January 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Oseltamivir Phosphate 75 mg capsules, a medication used to treat influenza. The contract has a firm fixed price of $3,424.95 and an ultimate completion date of July 29, 2024. The contract is a delivery order and is not associated with a set-aside program. It is part of a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,554.79 firm fixed-price delivery order contract is for the supply of 4,567,282,823 units of 30 mg Oseltamivir Phosphate capsules. The contract has a ceiling value of $3,554.79 and runs through February 18, 2025. This award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order under the Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,126.99 firm fixed-price contract is for the delivery of 4,566,703,864 units of Oseltamivir Phosphate 75 mg capsules, a medication used for the treatment of influenza. The contract has a performance period through December 13, 2024 and does not...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,964,230 units of the prescription drug Oseltamivir Phosphate 75 mg capsules, a medication used to treat and prevent influenza. The contract has a total ceiling value of $6,301.50 and a completion date of June 24, 2024. The contract is a firm fixed-price type and does not have...
This is a $1,541.28 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Oseltamivir Phosphate 75mg capsules. The award is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp as the sole awardee. This IDC serves as the primary vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support...
This federal contract award, valued at $6,584.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,557,653,420 units of Oseltamivir Phosphate 75 mg capsules, a medication used to treat and prevent influenza. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,307,107 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. The $5,284.09 firm-fixed-price contract has a completion date of November 4, 2024 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,987.17 firm fixed-price delivery order is for the purchase of 4,567,104,683 units of Oseltamivir Phosphate 75mg capsules, a medication used to treat influenza. The contract has an ultimate completion date of January 31, 2025 and was awarded on January 30, 2025. Amerisourcebergen holds a $999,999,999 Indefinite...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,394,389 units of Oseltamivir Phosphate 75 mg capsules. The contract has an ultimate completion date of January 23, 2024 and a ceiling value of $3,630.81. The award is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FPYB4
    Delivery Order

This is a $1,417.10 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of oseltamivir phosphate 75 mg capsules, which are used to treat influenza. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designations, indicating open competition.

Generated 4/17/25, 8:39 AM